NL-OMON21098已完成不适用
Mycophenol mofetil in Antiretroviral Naïve patients 2 (MAN2 study).
AMC-NATEC0 个研究点目标入组 90 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patient is ≥ 18 years of age;
- •2. Patient has a proven HIV-1 infection (with antibodies against HIV-1 and a detectable plasma HIV-1 RNA measured for the first time at least 6 months prior to inclusion);
排除标准
- •1. Plasma HIV-1 RNA < 10.000 copies/ mL;
- •2. Autoimmune disease;
研究者
相似试验
已完成
不适用
Mycophenolate mofetil in Antiretroviral Naive patients 2 (MAN2 study)ISRCTN43218409Academic Medical Centre (AMC) (Netherlands)90
Unknown
4 期
Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)HIV InfectionNCT00120419Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)90
已完成
不适用
Mycophenolate mofetil treatment in a patient with frequently relapsing nephrotic syndromefrequently relapsing nephrotic syndromeJPRN-UMIN000007511Kumamoto University, Faculty of Life Sciences, Department of Pediatrics1
Unknown
4 期
Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected PatientsHIV InfectionAtherosclerosisNCT00247494Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)90
尚未招募
不适用
Monitoring of Plasma Levels of Mycophenolate Mofetil (MMF) in Renal Transplant RecipientsCTRI/2018/08/015214Investigator initiated trial